If Indianapolis-based Anthem retreats from the Affordable Care Act, it would mean that almost all of the major American for-profit health insurers have substantially pulled back from the law.
The health insurance giant saw its largest expense, medical claims paid, climb more than 9 percent in the quarter, to $16.92 billion.
Makers of insulin became the latest target for Sen. Bernie Sanders, who has been going after pharmaceutical companies one by one over the issue of high U.S. drug prices.
Franciscan Health said the complex at U.S. 135 and Stones Crossing Road will serve a rapidly growing part of Johnson County. It will be about 12 miles from its hospitals in Indianapolis and Mooresville.
TriMedx, a provider of health care technology management services, said it would invest the money in its 78,000-square-foot corporate headquarters near West 71st Street and Zionsville Road and elsewhere in the state.
In the largest project in its history, Johnson Memorial plans to demolish its old hospital building and construct two new health care facilities.
Community said having Walgreens run its pharmacies will give its patients access to more pharmacy locations with expanded hours. The hospital network also was impressed by Walgreens' technology that allows patients to interact with the pharmacy digitally.
The project, expected to take 18 months, will raze 900,000 square feet of adjoining buildings on a 15-acre site.
Americans in the health insurance markets created by President Barack Obama's law will have less choice next year than any time since the program started.
Since 2012, the company has built five buildings, refurbished existing buildings, made upgrades to IT infrastructure, and increased investments in its diabetes care manufacturing technology.
Drugmakers including Eli Lilly and Co. are becoming increasingly vocal in fighting a California ballot proposition designed to bring down prices on prescription medicine.
Sales of Lilly's Humalog insulin, its top-selling product, fell 9 percent, to $641 million, offsetting gains by a stable of new drugs that is helping the company weather a blitz of patent expirations.
Obamacare premiums will go up sharply next year under and many consumers will be down to just one insurer to choose from, the administration confirmed Monday.
The new degree blends such disciplines as biostatistics, computer science and informatics to better understand issues related to health care cost and quality.
The hospital voluntarily closed the rooms Oct. 10 after finding discoloration on ceiling tiles and walls in a nearby corridor area.
Starting Jan. 1, any health care organization that takes federal money for health purposes can’t refuse to provide transgender services.
Lartruvo is the first front-line therapy approved by the FDA to treat soft tissue sarcomas since doxorubicin more than 40 years ago.
Currently, only about 2-4 percent of U.S. brain surgeries for tumors, strokes and other abnormalities are done with NICO’s low-invasive approach.
Research developed at Purdue University and licensed by a biomedical startup could give patients with late-stage prostate cancer an alternative to hormone therapies that can develop resistance after prolonged use.
This is shaping up to be the most difficult sign-up season since HealthCare.gov launched in 2013. Premiums are going up sharply in many parts of the country, and some major insurers have exited the program, leaving consumers with fewer choices.
